113 related articles for article (PubMed ID: 11282220)
21. Effect of atorvastatin on endothelium-dependent vasodilation in postmenopausal women with average serum cholesterol levels.
Mercuro G; Zoncu S; Saiu F; Sarais C; Rosano GM
Am J Cardiol; 2002 Oct; 90(7):747-50. PubMed ID: 12356389
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of impairment of endothelium-dependent relaxation to acetylcholine in Watanabe heritable hyperlipidaemic rabbit aortas.
Kagota S; Yamaguchi Y; Shinozuka K; Kunitomo M
Clin Exp Pharmacol Physiol; 1998 Feb; 25(2):104-9. PubMed ID: 9493497
[TBL] [Abstract][Full Text] [Related]
23. Effects of simvastatin on endothelial function after chronic inhibition of nitric oxide synthase by L-NAME.
Pérez-Guerrero C; Alvarez de Sotomayor M; Jimenez L; Herrera MD; Marhuenda E
J Cardiovasc Pharmacol; 2003 Aug; 42(2):204-10. PubMed ID: 12883323
[TBL] [Abstract][Full Text] [Related]
24. Atorvastatin prevents endothelial dysfunction in mesenteric arteries from spontaneously hypertensive rats: role of cyclooxygenase 2-derived contracting prostanoids.
Virdis A; Colucci R; Versari D; Ghisu N; Fornai M; Antonioli L; Duranti E; Daghini E; Giannarelli C; Blandizzi C; Taddei S; Del Tacca M
Hypertension; 2009 Jun; 53(6):1008-16. PubMed ID: 19380610
[TBL] [Abstract][Full Text] [Related]
25. Endothelial dysfunction in spontaneously hypertensive rats: consequences of chronic treatment with losartan or captopril.
Rodrigo E; Maeso R; Muñoz-García R; Navarro-Cid J; Ruilope LM; Cachofeiro V; Lahera V
J Hypertens; 1997 Jun; 15(6):613-8. PubMed ID: 9218180
[TBL] [Abstract][Full Text] [Related]
26. Counter-regulation by atorvastatin of gene modulations induced by L-NAME hypertension is associated with vascular protection.
Nadaud S; Dupuis M; Brocheriou I; Haloui M; Louedec L; Capron F; Michel JB; Soubrier F
Vascul Pharmacol; 2009 Oct; 51(4):253-61. PubMed ID: 19586617
[TBL] [Abstract][Full Text] [Related]
27. Losartan reduces phenylephrine constrictor response in aortic rings from spontaneously hypertensive rats. Role of nitric oxide and angiotensin II type 2 receptors.
Maeso R; Navarro-Cid J; Muñoz-García R; Rodrigo E; Ruilope LM; Lahera V; Cachofeiro V
Hypertension; 1996 Dec; 28(6):967-72. PubMed ID: 8952584
[TBL] [Abstract][Full Text] [Related]
28. L-NAME hypertension alters endothelial and smooth muscle function in rat aorta. Prevention by trandolapril and verapamil.
Küng CF; Moreau P; Takase H; Lüscher TF
Hypertension; 1995 Nov; 26(5):744-51. PubMed ID: 7591013
[TBL] [Abstract][Full Text] [Related]
29. Preservation of endothelium-dependent and Nomega-nitro-L-arginine methyl ester- and indomethacin-resistant arterial relaxation in high-cholesterol-diet fed rabbits by treatment with fluvastatin, an HMG-CoA reductase inhibitor.
Mitani H; Kimura M
J Cardiovasc Pharmacol; 2003 Jul; 42(1):55-62. PubMed ID: 12827027
[TBL] [Abstract][Full Text] [Related]
30. Endothelium is required in the vascular spasm induced by tetraethylammonium and endothelin-1 in guinea-pig aorta.
Dorigo P; Maragno I; Santostasi G; Fraccarollo D
Br J Pharmacol; 1999 May; 127(2):505-13. PubMed ID: 10385252
[TBL] [Abstract][Full Text] [Related]
31. Correlation with blood pressure of the acetylcholine-induced endothelium-derived contracting factor in the rat aorta.
Iwama Y; Kato T; Muramatsu M; Asano H; Shimizu K; Toki Y; Miyazaki Y; Okumura K; Hashimoto H; Ito T
Hypertension; 1992 Apr; 19(4):326-32. PubMed ID: 1555864
[TBL] [Abstract][Full Text] [Related]
32. Contribution of constrictor prostanoids to the calcium-dependent basal tone in the aorta from rats with aortic coarctation-induced hypertension: relationship to nitric oxide.
Dellipizzi A; Pucci ML; Mosny AY; Deseyn K; Nasjletti A
J Pharmacol Exp Ther; 1997 Oct; 283(1):75-81. PubMed ID: 9336310
[TBL] [Abstract][Full Text] [Related]
33. HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species.
Wassmann S; Laufs U; Bäumer AT; Müller K; Ahlbory K; Linz W; Itter G; Rösen R; Böhm M; Nickenig G
Hypertension; 2001 Jun; 37(6):1450-7. PubMed ID: 11408394
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
35. CyA and OxLDL cause endothelial dysfunction in isolated arteries through endothelin-mediated stimulation of O(2)(-) formation.
Galle J; Lehmann-Bodem C; Hübner U; Heinloth A; Wanner C
Nephrol Dial Transplant; 2000 Mar; 15(3):339-46. PubMed ID: 10692519
[TBL] [Abstract][Full Text] [Related]
36. Chronic ET(A) receptor blockade prevents endothelial dysfunction of small arteries in apolipoprotein E-deficient mice.
d'Uscio LV; Barton M; Shaw S; Lüscher TF
Cardiovasc Res; 2002 Feb; 53(2):487-95. PubMed ID: 11827700
[TBL] [Abstract][Full Text] [Related]
37. Reduction of bFGF-induced smooth muscle cell proliferation and endothelin receptor mRNA expression by mevastatin and atorvastatin.
Xu CB; Stenman E; Edvinsson L
Biochem Pharmacol; 2002 Aug; 64(3):497-505. PubMed ID: 12147302
[TBL] [Abstract][Full Text] [Related]
38. Chronic inhibition of nitric-oxide synthase potentiates endothelium-dependent contractions in the rat aorta by augmenting the expression of cyclooxygenase-2.
Qu C; Leung SW; Vanhoutte PM; Man RY
J Pharmacol Exp Ther; 2010 Aug; 334(2):373-80. PubMed ID: 20444882
[TBL] [Abstract][Full Text] [Related]
39. Central role of intracellular calcium stores in acute flow- and agonist-evoked endothelial nitric oxide release.
Hutcheson IR; Griffith TM
Br J Pharmacol; 1997 Sep; 122(1):117-25. PubMed ID: 9298537
[TBL] [Abstract][Full Text] [Related]
40. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
Li P; Fukuhara M; Diz DI; Ferrario CM; Brosnihan KB
J Pharmacol Exp Ther; 2000 Jan; 292(1):238-46. PubMed ID: 10604953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
